PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 8 filers reported holding PDL BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $40,923,000 | +8.5% | 14,397,212 | 0.0% | 0.97% | -9.6% |
| Q2 2021 | $37,721,000 | +4.1% | 14,397,212 | 0.0% | 1.08% | -2.0% |
| Q1 2021 | $36,246,000 | +1.9% | 14,397,212 | 0.0% | 1.10% | +49.0% |
| Q4 2020 | $35,561,000 | +23.1% | 14,397,212 | +56.9% | 0.74% | -34.2% |
| Q3 2020 | $28,896,000 | +3307.5% | 9,173,408 | +2193.4% | 1.12% | +1595.5% |
| Q4 2016 | $848,000 | – | 400,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |